Facility Expansion at Abzena

Bioprocessing

Bioprocessing and Capacity Trends: Growth Despite Continued Uncertainty

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Pathfinder

Solid-Phase vs. Liquid-Phase Peptide Synthesis: Which Manufacturing Strategy Is Better?

Nice Insight

ADCs

How Lessons from Breast Cancer Are Shaping ADC Development Across Solid Tumors

David Alvaro, Ph.D.

Pharma's Almanac

Formulation Models

Predictive Formulation: Can Modeling Reduce Empirical Development?

David Alvaro, Ph.D.

Pharma's Almanac

Pathfinder

Spray-Dried Dispersions vs. Nanocrystals: Which Is Better for Solubility Enhancement?

Nice Insight

Viral CDMO

Choosing a CDMO That Can Grow with a Viral Program

Kai Lipinski, Ph.D.

Recipharm Advanced Bio

Viral Vectors

Gene Therapy Manufacturing After the Capacity Boom

David Alvaro, Ph.D.

Pharma's Almanac

Heme-Onc

Therapeutic and Diagnostic Advances Benefiting Patients with Hematologic Malignancies

Cynthia A. Challener, Ph.D.

Pharma's Almanac

Biocatalysis

When Does Biocatalysis Create the Better Manufacturing Process?

Yusho Kato

Kaneka

DS + DP Integration

Integrating Drug Substance and Drug Product to Reduce Risk Across Development

Dörthe Ackenhausen

IDT Biologika

Multi-Modality CDMO

The Rise of the Multi-Modality CDMO: Why Clients Need More Than Capacity

Kamal Preet

OneSource Specialty Pharma